½ÃÀ庸°í¼­
»óǰÄÚµå
1550576

¼¼°èÀÇ ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀå : Åõ¿© °æ·Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå

Drug Delivery Device Market, By Route of Administration, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2024³â 2,102¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³â±ä ¿¬Æò±Õ 8.8% ¼ºÀåÇÏ¿© 2031³â¿¡´Â 3,791¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼³»¿ë
±âÁس⵵ 2023³â 2024³â ½ÃÀå ±Ô¸ð 2,102¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â)ÀÇ CAGR: 8.80% 2031³â ±Ý¾× Àü¸Á 3,791¾ï 1,000¸¸ ´Þ·¯
±×¸². 2024³â ¾à¹°Àü´Þ ±â±â ½ÃÀå Á¡À¯À²(%), Áö¿ªº°
Drug Delivery Device Market-IMG1

¾à¹°Àü´Þ ±â±â¶õ ÀǾà È­ÇÕ¹°À» ü³»·Î ¿î¹ÝÇϱâ À§ÇØ »ç¿ëµÇ´Â ´Ù¾çÇÑ ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ¾à¹° Àü´ÞÀ» È¿°úÀûÀ¸·Î ¼öÇàÇÔÀ¸·Î½á ÀÛ¿ë ºÎÀ§¿¡ ÀûÀýÇÑ ³óµµÀÇ À¯È¿¼ººÐÀÌ ÀÛ¿ëÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌ´Â ¾à¹°ÀÇ È¿´É°ú ȯÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ÀÇ ±Þ¼ÓÇÑ ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇ·á, ¸¸¼º Áúȯ Áõ°¡·Î ÀÎÇØ ÷´Ü ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÈÀü¼º, Á¤È®¼º ¹× »ç¿ë ÆíÀǼº Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃá ¾à¹° Àü´Þ ÀåÄ¡ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº °¡±î¿î ¹Ì·¡¿¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°è ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í ÀÇ·áºñ ÁöÃâ Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª °íµµÀÇ Àü´Þ ½Ã½ºÅÛ °³¹ß¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Çõ½ÅÀûÀÎ Á¦Ç°¿¡ ´ëÇÑ ±ÔÁ¦ À庮µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï±¹Àº ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÚ°¡ Åõ¿© ÁÖ»ç±â ¹× ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ¹× Âø¿ëÇü Àü´Þ ½Ã½ºÅÛÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüµµ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. »ç¹°ÀÎÅͳÝÀ» Áö¿øÇÏ´Â ½º¸¶Æ® ±â±âÀÇ Ã¤ÅÃÀº ½ÃÀåÀÇ ÁÖ¿ä Æ®·»µåÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(¹ÌÈ­ 10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

¼¼°è ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅ͸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.

ÀÌ Á¶»ç ´ë»ó¿¡´Â Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, Nemera µî ÁÖ¿ä ±â¾÷ÀÌ Æ÷ÇԵƽÀ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¾à¹° Àü´Þ ÀåÄ¡ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾à¹° Àü´Þ ÀåÄ¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ ¾à¹°Àü´Þ ±â±â ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2031³â(10¾ï ´Þ·¯)

  • °æ±¸
  • ºñ°æ±¸
  • °æÇÇ
  • Ocular

Á¦5Àå ¼¼°èÀÇ ¾à¹°Àü´Þ ±â±â ½ÃÀå, ¿ëµµº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Á¾¾çÇÐ
  • °¨¿°Áõ
  • È£Èí±â Áúȯ
  • ´ç´¢º´
  • ½ÉÇ÷°ü Áúȯ
  • ÀÚ°¡¸é¿ª Áúȯ
  • ÁßÃ߽Űæ°è Áúȯ

Á¦6Àå ¼¼°èÀÇ ¾à¹°Àü´Þ ±â±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • º´¿ø
  • Áø´Ü¼¾ÅÍ
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)/Ŭ¸®´Ð
  • °¡Á¤Ä¡·á ȯ°æ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¾à¹°Àü´Þ ±â±â ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦8Àå °æÀï ±¸µµ

  • Abbott Laboratories
  • Adherium Ltd.
  • Amiko Digital Health Limited
  • Becton, Dickinson and Company
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • COM(Coherent Opportunity Map)

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç
LSH 24.09.23

Global drug delivery device market is estimated to be valued at USD 210.20 Bn in 2024 and is expected to reach USD 379.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 210.20 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 8.80% 2031 Value Projection: US$ 379.11 Bn
Figure. Drug Delivery Device Market Share (%), By Region 2024
Drug Delivery Device Market - IMG1

Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.

Market Dynamics:

Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.

Key features of the study:

This report provides in-depth analysis of the global drug delivery device market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market

Detailed Segmentation-

  • By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
    • Oral
    • Parenteral
    • Transdermal
    • Ocular
    • Pulmonary
  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Oncology
    • Infectious Diseases
    • Respiratory Diseases
    • Diabetes
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Central Nervous System Disorders
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Surgery Centers/Clinics
    • Home Care Settings
    • Others
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Adherium Ltd.
    • Amiko Digital Health Limited
    • Becton, Dickinson and Company
    • BIOCORP
    • CeQur Corporation
    • Cognita Labs
    • E3D Elcam Drug Delivery Devices
    • H&T Presspart Manufacturing Ltd.
    • HCmed Innovations Co., Ltd.
    • Medtronic plc
    • Novo Nordisk A/S
    • Phillips-Medisize
    • Sonceboz
    • Enable Injections, Inc.
    • NOVO Engineering
    • Elcam Medical
    • Battelle
    • Gerresheimer AG
    • Aphios

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Drug Delivery Device Market, By Route of Administration
    • Global Drug Delivery Device Market, By Application
    • Global Drug Delivery Device Market, By End User
    • Global Drug Delivery Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Drug Delivery Device Market, By Route of Administration, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ocular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Delivery Device Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Central Nervous System Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Delivery Device Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ambulatory Surgery Centers/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Delivery Device Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Adherium Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amiko Digital Health Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦